Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$13.14 -0.23 (-1.72%)
At close: Sep 4, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Convertible Debt (2011)

Tonix Pharmaceuticals Holding (TNXP) posted Convertible Debt of $2.1 million for Q4 2011.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Convertible Debt (2011) Analysis & Trends

Tonix Pharmaceuticals Holding has reported Convertible Debt for 1 years, with the latest figure at $2.1 million in Q4 2011.

  • On a quarterly basis, Convertible Debt changed N/A year-over-year to $2.1 million in Q4 2011; TTM through Dec 2011 was $2.1 million, a N/A change from a year earlier, with the FY2011 full-year figure at $2.1 million, changed N/A from the prior year.
  • Convertible Debt was $2.1 million for Q4 2011 at Tonix Pharmaceuticals Holding.
  • The five-year high for Convertible Debt was $2.1 million in Q4 2011, with the low at $2.1 million in Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
10 Tonix Pharmaceuticals Holding 220.65 Mn 220.65 Mn 12.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 2.08 Mn